Evidence map›Paper›PMID 33859209›Full record

ArticleScientific reports2021

Optimising assessment of dark adaptation data using time to event analysis.

Bethany E Higgins, Giovanni Montesano, Alison M Binns, David P Crabb

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Reply.Ophthalmology science · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bethany E HigginsOptometry and Visual Sciences, School of Health Sciences, City, University of London Northampton Square, London, EC1V 0HB, UK.ORCID 0000-0002-4530-6156
Giovanni MontesanoOptometry and Visual Sciences, School of Health Sciences, City, University of London Northampton Square, London, EC1V 0HB, UK.ORCID 0000-0002-9148-2804
Alison M BinnsOptometry and Visual Sciences, School of Health Sciences, City, University of London Northampton Square, London, EC1V 0HB, UK.ORCID 0000-0001-8621-498X
David P CrabbOptometry and Visual Sciences, School of Health Sciences, City, University of London Northampton Square, London, EC1V 0HB, UK. david.crabb.1@city.ac.uk.ORCID 0000-0001-8754-3902

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In age-related macular degeneration (AMD) research, dark adaptation has been found to be a promising functional measurement. In more severe cases of AMD, dark adaptation cannot always be recorded within a maximum allowed time for the test (~ 20-30 min). These data are recorded either as censored data-points (data capped at the maximum test time) or as an estimated recovery time based on the trend observed from the data recorded within the maximum recording time. Therefore, dark adaptation data can have unusual attributes that may not be handled by standard statistical techniques. Here we show time-to-event analysis is a more powerful method for analysis of rod-intercept time data in measuring dark adaptation. For example, at 80% power (at α = 0.05) sample sizes were estimated to be 20 and 61 with uncapped (uncensored) and capped (censored) data using a standard t-test; these values improved to 12 and 38 when using the proposed time-to-event analysis. Our method can accommodate both skewed data and censored data points and offers the advantage of significantly reducing sample sizes when planning studies where this functional test is an outcome measure. The latter is important because designing trials and studies more efficiently equates to newer treatments likely being examined more efficiently.

Indexed as

Adaptation, OcularDark AdaptationAgedData CollectionFemaleHumansMacular DegenerationMaleMiddle AgedOutcome Assessment, Health CareSample SizeTime Factors

Identifiers

PMID33859209
PMCPMC8050245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.